Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
09939 KINTOR PHARMA-B
RT Nominal down1.060 -0.010 (-0.935%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others178,708-3.069%184,366240,250223,686174,612
Land & other Lease Assets12,699-66.115%37,47742,22738,61412,068
Intangible Assets149,0030.042%148,940235,648235,621209,760
Interests in Asso. & JCEs17,9970.000%17,99717,94500
Other Non-current Assets9,78423.927%7,89511,19744,17334,419

368,191-7.181%396,675547,267542,094430,859
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories200--0603,503351,3620
Trade Receivables0--0000
Cash & Bank Balances322,656-27.574%445,499865,081930,1491,065,588
Other Current Assets25,110-7.199%27,05839,285244,384355,028
Assets Held for Sale23,384--0000

371,350-21.417%472,5571,507,8691,525,8951,420,616
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables46,994-42.410%81,601180,401172,95628,811
S-T Debt & Leases178,89151.308%118,230103,3359,46986,313
Other Current Liabilities12,371-50.315%24,89934,39137,31554,209
Liab asso w/ Assets Held for Sale0--0000

238,2566.019%224,730318,127219,740169,333
Net Current Assets133,094-46.296%247,8271,189,7421,306,1551,251,283
Total Assets Less Current Liabilities501,285-22.221%644,5021,737,0091,848,2491,682,142
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases59,907-55.850%135,690183,051150,264135,390
Other Non-current Liabilities49,803-1.769%50,70058,77042,82738,818

109,710-41.140%186,390241,821193,091174,208
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital3150.000%315315273261
  Reserves391,260-14.534%457,7971,494,8731,654,8851,507,673
  Others0--0000
Shareholders' Funds391,575-14.524%458,1121,495,1881,655,1581,507,934
Non-controlling Interests0--0000
Others0--0000

391,575-14.524%458,1121,495,1881,655,1581,507,934
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----44,62847,25417,64234,019
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 27/11/2024 10:57
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -71,493,000
%Change-66.295%
EPS / (LPS)RMB -0.170
NBV Per Share (¥)RMB 0.875
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.